Rezolve AI Ltd (RZLV) concluded trading on Wednesday at a closing price of $1.77, with 4.89 million shares of worth about $8.65 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -76.65% during that period and on March 12, 2025 the price saw a gain of about 25.98%. Currently the company’s common shares owned by public are about 308.57M shares, out of which, 122.18M shares are available for trading.
Stock saw a price change of 12.74% in past 5 days and over the past one month there was a price change of -47.16%. Year-to-date (YTD), RZLV shares are showing a performance of -53.66% which decreased to -83.98% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.27 but also hit the highest price of $14.50 during that period. The average intraday trading volume for Rezolve AI Ltd shares is 11.05 million. The stock is currently trading -15.42% below its 20-day simple moving average (SMA20), while that difference is down -34.38% for SMA50 and it goes to -72.10% lower than SMA200.
Rezolve AI Ltd (NASDAQ: RZLV) currently have 308.57M outstanding shares and institutions hold larger chunk of about 0.89% of that.
The stock has a current market capitalization of $546.17M and its 3Y-monthly beta is at -0.43. It has posted earnings per share of -$0.34 in the same period. It has Quick Ratio of 0.01 while making debt-to-equity ratio of 0.65. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for RZLV, volatility over the week remained 11.58% while standing at 11.10% over the month.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Maxim Group on January 16, 2025 offering a Buy rating for the stock and assigned a target price of $10 to it. Coverage by Northland Capital stated Rezolve AI Ltd (RZLV) stock as an Outperform in their note to investors on December 18, 2024, suggesting a price target of $5 for the stock. On December 10, 2024, ROTH MKM Initiated their recommendations, while on December 05, 2024, Cantor Fitzgerald Initiated their ratings for the stock with a price target of $5.
